Form 4: Scholar Rock Holding Corp: CEO David Hallal Acquires Stock Options
SEC Form 4
CEO David Hallal of Scholar Rock Holding Corp. acquired stock options for 275,167 shares on May 2, 2025, according to a Form 4 filing.
Summary
- David Hallal, the CEO of Scholar Rock Holding Corp, acquired stock options on May 2, 2025.
- The options grant him the right to buy 275,167 shares of common stock at an exercise price of $32.91.
- These options vest over time, starting with 25% vesting on April 27, 2026, and the remainder vesting in equal quarterly installments over the following three years, contingent upon continued service with the company.
- Following the transaction, Hallal directly owns options for 275,167 shares.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard executive compensation disclosure. The grant itself is neither overwhelmingly positive nor negative, but rather a routine part of executive compensation.
Positives
- The acquisition of stock options by the CEO could align his interests with those of the shareholders, incentivizing him to improve the company's performance.
- The vesting schedule encourages long-term commitment from the CEO.
Future Outlook
The vesting schedule suggests an expectation of continued service and leadership from the CEO over the next several years.
Industry Context
Stock option grants are a common form of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.
Comparison to Industry Standards
- Executive compensation packages, including stock options, are common in the biotech industry.
- Companies like Amgen, Gilead Sciences, and Biogen often use stock options as part of their executive compensation to align management incentives with shareholder value.
- The vesting schedule and exercise price would need to be compared to similar companies to determine if they are in line with industry standards.
Stakeholder Impact
- The stock option grant could potentially benefit shareholders if it incentivizes the CEO to improve company performance and increase shareholder value.
- The vesting schedule ensures the CEO's long-term commitment to the company.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of the stock option transaction. |
| 05/02/2025 | Date of the stock option grant. |
| 04/27/2026 | Date when 25% of the stock options vest. |
| 05/02/2035 | Expiration date of the stock options. |
| 05/06/2025 | Date of the form signature. |
Keywords
stock options, Form 4, David Hallal, Scholar Rock Holding Corp, SRRK, CEO, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.